NANOMOL-BIO group is devoted to the synthesis, physicochemical characterization and development, up to pre-clinical regulatory phases, of molecular and polymeric (nano)materials for biomedical applications: (i) therapy, (ii) diagnosis, (iii) prevention, and (iv) regenerative medicine.
Nanomol-bio together with e-MolMat constitute the Nanomol Research Unit. Nanomol is member of the Biomedical Research Network (CIBER) in the area of Bioengineering, Biomaterials and Nanomedicine; and is awarded with the TECNIO label given to Catalan research unites with high innovative and tech transfer capacities. Both groups have been recognized as Consolidated Research Groups (GRC) by the Generalitat de Catalunya through the SGR recognition.